- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02615977
Learning and Relapse Risk in Alcohol Dependence (FP2) (LeAD_FP2)
Learning and Decision Making as Predictors of Treatment Outcome in Alcohol Use Disorder (Funding Period 2)
The investigators will examine clinical alterations in learning and automated approach behaviour and their neurobiological correlates in alcohol-dependent patients and healthy social drinkers and assess whether they are affected by a Zooming Joystick Training (ZJT; randomized "verum" versus "placebo" training) which trains subjects to habitually push alcohol pictures away.
The investigators will test whether activations following treatment predict relapse rate (primary outcome measure) and the prospective amount of alcohol intake (secondary outcome measure) within a six-month follow-up period.
Using fMRI, the investigators will use the Pavlovian-to-Instrumental-Transfer (PIT) paradigm established during the first funding period to distinguish the effects of appetitive, aversive, and drug-related Pavlovian cues on automated instrumental approach behaviour and to assess ZJT training effects comparing functional activation before and after ZJT training.
The investigators will also scan subjects during performance of a short standard working memory task. Behaviourally, aspects of impulsivity will be assessed with the Value-Based Decision Making (VBDM) Battery. Scanning will be repeated after ZJT training to assess its effects on the neural correlates of Pavlovian-to-Instrumental transfer (PIT).
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This Project will examine 130 detoxified alcohol-dependent patients and 40 age- and gender matched controls. All subjects will be treated with Zooming Joystick Task (ZJT) training to alter a habitual alcohol cue approach bias. The primary aim of this project is to assess
- which behavioural and neuroimaging alterations (fMRI) associated with reward-based learning are altered by ZJT treatment and which alterations predict treatment outcome (primary outcome: relapse, secondary outcome: amount of alcohol intake) within the follow-up period of 6 months,
- how these alterations interact with clinical and psychosocial factors that can modify relapse risk, and
- to provide data for genetic and imaging analyses and modelling. Furthermore, the investigators will explore gender effects on functional imaging parameters of learning.
Patients will be detoxified in an inpatient setting, receive six sessions of the ZJT in a randomized placebo controlled design and will be followed for six months using the Time-Line Follow-Back Procedure. Clinical assessments, behavioural paradigms of learning, and brain imaging will be carried out within at least four half-lives after any psychotropic medication. Subjects will undergo medical management with biweekly follow-ups and predefined inclusion and exclusion criteria as previously described. Functional imaging paradigms will be applied, assessing
- Pavlovian-to-instrumental transfer,
- habitual versus goal directed behaviour and
- working memory.
The investigators will associate model parameters of learning with functional activation and prospective intake controlling for comorbidity, psychosocial and neurobiological disease severity markers.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Berlin, Germany, 10117
- Charité - Universitätsmedizin Berlin
-
Dresden, Germany, 01187
- Technische Universität Dresden
-
-
Saxony
-
Dresden, Saxony, Germany, 01307
- Universitaetsklinikum Carl Gustav Carus at the Technische Universitaet Dresden
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Men and women aged 18-65 years
- alcohol dependence/alcohol use disorder according to ICD-10 and alcohol-use disorder according to DSM-5
- Minimum of 72 hours of abstinence, maximum of 21 days of abstinence
- Minimum of three years with alcohol dependence/alcohol use disorder
- Low severity of withdrawal symptoms
- Ability to provide fully informed consent and to use self-rating scales
- Sufficient understanding of the German language
Exclusion Criteria:
- Lifetime history of DSM-IV bipolar, psychotic disorder, or substance dependence other than nicotine dependence. Patients may have had lifetime alcohol dependence/alcohol use disorder diagnoses.
- Current threshold DSM-IV diagnosis of any of the following disorders: current (hypo)manic episode, major depressive disorder, generalized anxiety disorder, PTSD, borderline personality disorder, or obsessive compulsive disorder
- History of substance dependence other than alcohol or nicotine dependence
- Current substance use other than nicotine and alcohol as evinced by positive urine test
- History of severe head trauma or other severe central neurological disorder (dementia, Parkinson's disease, multiple sclerosis)
- Pregnancy or nursing infants
- Any alcohol intake within the last 24 hours
- Use of medications or drugs known to interact with the central nervous system within the last 10 days, except detoxification treatment with benzodiazepines or clomethiazole, with testing at least four half-lives post last intake
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Intervention
In the "verum treatment condition", i.e.
Zooming Joystick Task, 90% of all alcohol-related pictures appear in the landscape format and hence are trained to be pushed away.
|
Subjects are instructed to use the joystick to pull all pictures (alcoholic and non-alcoholic beverages) towards them that appear in the portrait format, while pictures in a landscape format are pushed away. Half of the pictures are alcohol-related and the other half is not. The assignment of stimuli (alcohol versus neutral) to the picture format (portrait versus landscape) is manipulated (see 'Study Arm' descriptions). Arousal and valence of the alcohol and non-alcohol pictures is rated as previously described. The investigators will apply six sessions of ZJT training, as this number has been proven sufficient for reducing relapse rates.
Other Names:
|
|
Placebo Comparator: Placebo Intervention
In the placebo condition, i.e.
Zooming Joystick Task (Placebo), alcohol picture are as often pushed away as pulled towards the subject.
|
Subjects are instructed to use the joystick to pull all pictures (alcoholic and non-alcoholic beverages) towards them that appear in the portrait format, while pictures in a landscape format are pushed away. Half of the pictures are alcohol-related and the other half is not. The assignment of stimuli (alcohol versus neutral) to the picture format (portrait versus landscape) is manipulated (see 'Study Arm' descriptions). Arousal and valence of the alcohol and non-alcohol pictures is rated as previously described. The investigators will apply six sessions of ZJT training, as this number has been proven sufficient for reducing relapse rates.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
relapse to heavy drinking
Time Frame: 6 months
|
defined as the consumption of over 60g of alcohol per occasion in men and of over 40g of alcohol in women
|
6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
amount of alcohol intake during the follow-up period
Time Frame: 6 months
|
Timeline Followback interview for each day during the follow-up period
|
6 months
|
|
blood oxygenation level-dependent (BOLD) signal
Time Frame: at assessment and after last training (approx. 2 weeks after assessment)
|
at assessment and after last training (approx. 2 weeks after assessment)
|
Collaborators and Investigators
Sponsor
Investigators
- Study Chair: Andreas Heinz, Prof PhD MD, Charite University, Berlin, Germany
Publications and helpful links
Helpful Links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- HE2597/142;ZI1119/32;WI709/102
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Alcohol Use Disorder
-
Washington State UniversityRecruitingNicotine Use Disorder | Alcohol Use Disorder (AUD)United States
-
Technische Universität DresdenCharite University, Berlin, Germany; Central Institute of Mental Health, MannheimRecruitingAlcoholism | Methamphetamine-dependence | Substance Use Disorders | Cocaine Use Disorder | Alcohol Use Disorder (AUD) | Cannabis Use Disorder | Amphetamine Use DisorderGermany
-
Indiana UniversityPatient-Centered Outcomes Research InstituteRecruitingAdolescent | Alcohol Use | Mild Alcohol Use Disorder | Mild Substance Use DisorderUnited States
-
University of North Carolina, Chapel HillCompletedAlcohol Use Disorder, Mild | Alcohol Use Disorder, ModerateUnited States
-
University of BernRecruitingAlcohol Use Disorder (AUD) | Substance Use Disorder (SUD) | Cocaine Use Disorder (CUD)Switzerland
-
Université du Québec à Trois-RivièresCompletedAlcohol Use, Unspecified | Alcohol Use Disorder, MildCanada
-
Woebot HealthStanford UniversityCompletedSubstance Use Disorders | Alcohol Use Disorder (AUD)United States
-
University of Wisconsin, MadisonNational Institute on Alcohol Abuse and Alcoholism (NIAAA)Not yet recruitingAlcohol Use Disorder | Alcohol Use Disorder (AUD)United States
-
Technische Universität DresdenCharite University, Berlin, Germany; Central Institute of Mental Health, MannheimRecruitingAlcoholism | Substance Use Disorders | Alcohol Use Disorder (AUD)Germany
-
University of Notre DameNational Institute on Alcohol Abuse and Alcoholism (NIAAA)RecruitingAlcohol Use | Opioid Use Disorder | Alcohol Use Disorder | Opioid UseUnited States
Clinical Trials on Zooming Joystick Task
-
University of PittsburghHuman Engineering Research LaboratoriesCompletedCerebral Palsy | Spasticity
-
The Fuzhou No 2 HospitalActive, not recruitingTibial FractureChina
-
Rabin Medical CenterOno Academic CollegeUnknown
-
MGH Institute of Health ProfessionsShenzhen People's HospitalCompleted
-
Baskent UniversityCompletedStroke | Hemiplegia | Neuronal PlasticityTurkey
-
Riphah International UniversityActive, not recruiting
-
University of Sao PauloCompleted
-
Hugo W. Moser Research Institute at Kennedy Krieger...National Institute of Mental Health (NIMH)RecruitingPhysical Activity | Sleep | Attention Deficit Hyperactivity Disorder (ADHD)United States
-
Centre Hospitalier St AnneInstitut du Cerveau et de la Moelle (ICM Institute)UnknownDepression | SchizophreniaFrance
-
Igdir UniversityNot yet recruiting